Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration

被引:45
|
作者
Roh, Miin [1 ]
Selivanova, Alexandra [1 ]
Shin, Hyun Joon [2 ]
Miller, Joan W. [1 ]
Jackson, Mary Lou [3 ]
机构
[1] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA
[2] Harvard Med Sch, Dept Med, VA Boston Hlth Care syst, Div Aging,Brigham & Womens Hosp, Boston, MA USA
[3] VGH Univ British Coumbia, Eye Care Ctr, Vancouver, BC, Canada
来源
PLOS ONE | 2018年 / 13卷 / 05期
关键词
FUNCTION QUESTIONNAIRE; ASSOCIATION; DISABILITY; VALIDITY; THERAPY;
D O I
10.1371/journal.pone.0196481
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose Vision loss from age-related macular degeneration (AMD) has a profound effect on vision-related quality of life (VRQoL). The pupose of this study is to identify clinical factors associated with VRQoL using the Rasch- calibrated NEI VFQ-25 scales in bilateral advanced AMD patients. Methods We retrospectively reviewed 47 patients (mean age 83.2 years) with bilateral advanced AMD. Clinical assessment included age, gender, type of AMD, high contrast visual acuity (VA), history of medical conditions, contrast sensitivity (CS), central visual field loss, report of Charles Bonnet Syndrome, current treatment for AMD and Rasch-calibrated NEI VFQ-25 visual function and socioemotional function scales. The NEI VFQ visual function scale includes items of general vision, peripheral vision, distance vision and near vision-related activity while the socioemotional function scale includes items of vision related-social functioning, role difficulties, dependency, and mental health. Multiple regression analysis (structural regression model) was performed using fixed item parameters obtained from the one-parameter item response theory model. Results Multivariate analysis showed that high contrast VA and CS were two factors influencing VRQoL visual function scale (beta = -0.25, 95% CI-0.37 to -0.12, p<0.001 and beta = 0.35, 95% CI 0.25 to 0.46, p<0.001) and socioemontional functioning scale (beta = -0.2, 95% CI -0.37 to -0.03, p = 0.023, and beta = 0.3, 95% CI 0.18 to 0.43, p = 0.001). Central visual field loss was not assoicated with either VRQoL visual or socioemontional functioning scale (beta = -0.08, 95% CI-0.28 to 0.12,p = 0.44 and beta = -0.09, 95% CI -0.03 to 0.16, p = 0.50, respectively). Conclusion In patients with vision impairment secondary to bilateral advanced AMD, high contrast VA and CS are two important factors affecting VRQoL.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Assessment of vision-related quality of life and depression in patients with age-related macular degeneration
    Dogan, Levent
    Tanriverdi, Derya
    Gungor, Kivanc
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (SUPPL 2) : S293 - S297
  • [2] Metamorphopsia and vision-related quality of life among patients with age-related macular degeneration
    Xu, Kunyong
    Gupta, Vasudha
    Bae, Steven
    Sharma, Sanjay
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2018, 53 (02): : 168 - 172
  • [3] Vision-Related Quality of Life among Patients with Different Types of Age-Related Macular Degeneration
    Abdin, Alaa Din
    Eppinger, Anna
    Aljundi, Wissam
    Abu-Dail, Yaser
    Munteanu, Cristian
    Weinstein, Isabel
    Seitz, Berthold
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (03) : 283 - 291
  • [4] Intersession Repeatability of Contrast Sensitivity Scores in Age-Related Macular Degeneration
    Patel, Praveen J.
    Chen, Fred K.
    Rubin, Gary S.
    Tufail, Adnan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (06) : 2621 - 2625
  • [5] Mental health and visual acuity in patients with age-related macular degeneration
    Fonteh, Cheryl N.
    Mathias, Marc T.
    Mandava, Naresh
    Manoharan, Niranjan
    Lynch, Anne M.
    Navo, Roxanne
    Patnaik, Jennifer L.
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [6] Quality of Vision Index: a new method to appraise visual function changes in age-related macular degeneration
    Piemarocchi, Stefano
    Varano, Monica
    Parravano, Mariacristina
    Oddone, Francesco
    Sartore, Mauro
    Ferrara, Roberto
    Sera, Francesco
    Virgili, Gianni
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 (01) : 55 - 66
  • [7] INTRAVITREAL BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH GOOD VISUAL ACUITY
    Axer-Siegel, Ruth
    Bor, Elite
    Bourla, Dan H.
    Weinberger, Dov
    Mimouni, Karin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1811 - 1820
  • [8] Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial
    Ramakrishnan, Meera S.
    Yu, Yinxi
    VanderBeek, Brian L.
    JAMA OPHTHALMOLOGY, 2020, 138 (03) : 237 - 242
  • [9] The Significance of External Limiting Membrane Status for Visual Acuity in Age-Related Macular Degeneration
    Oishi, Akio
    Hata, Masayuki
    Shimozono, Masataka
    Mandai, Michiko
    Nishida, Akihiro
    Kurimoto, Yasuo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (01) : 27 - 32
  • [10] Advanced age-related macular degeneration and risk factors in eyes with pachydrusen
    Nam, Seung Wan
    Noh, Hoon
    Yoon, Je Moon
    Ham, Don-Il
    SCIENTIFIC REPORTS, 2024, 14 (01)